Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Short term Debt: 2012-2024

Historic Short term Debt for Veracyte (VCYT) over the last 6 years, with Dec 2024 value amounting to $17.0 million.

  • Veracyte's Short term Debt rose 83.62% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 83.62%. This contributed to the annual value of $17.0 million for FY2024, which is 539.10% up from last year.
  • According to the latest figures from FY2024, Veracyte's Short term Debt is $17.0 million, which was up 539.10% from $2.7 million recorded in FY2023.
  • Veracyte's 5-year Short term Debt high stood at $17.0 million for FY2024, and its period low was $2.7 million during FY2023.
  • Moreover, its 3-year median value for Short term Debt was $6.1 million (2022), whereas its average is $8.6 million.
  • Its Short term Debt has fluctuated over the past 5 years, first tumbled by 56.16% in 2023, then surged by 539.10% in 2024.
  • Veracyte's Short term Debt (Yearly) stood at $2.7 million in 2021, then soared by 125.95% to $6.1 million in 2022, then slumped by 56.16% to $2.7 million in 2023, then soared by 539.10% to $17.0 million in 2024.